156 related articles for article (PubMed ID: 16290943)
1. Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.
Mortensen MW; Sørensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
Appl Radiat Isot; 2006 Mar; 64(3):315-24. PubMed ID: 16290943
[TBL] [Abstract][Full Text] [Related]
2. Functionalization and cellular uptake of boron carbide nanoparticles. The first step toward T cell-guided boron neutron capture therapy.
Mortensen MW; Björkdahl O; Sørensen PG; Hansen T; Jensen MR; Gundersen HJ; Bjørnholm T
Bioconjug Chem; 2006; 17(2):284-90. PubMed ID: 16536457
[TBL] [Abstract][Full Text] [Related]
3. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy.
Raddatz S; Marcello M; Kliem HC; Tröster H; Trendelenburg MF; Oeser T; Granzow C; Wiessler M
Chembiochem; 2004 Apr; 5(4):474-82. PubMed ID: 15185371
[TBL] [Abstract][Full Text] [Related]
5. [Lethal effect of boron neutron capture reaction on human uveal melanoma cells in culture incubated with borophenylalanine].
Belkhou R; Mykita S; Meyer L; Sahel J; Abbé JC; Dreyfus H; Massarelli R
C R Acad Sci III; 1992; 315(12):485-91. PubMed ID: 1297526
[TBL] [Abstract][Full Text] [Related]
6. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
9. A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).
Suzuki M; Endo K; Satoh H; Sakurai Y; Kumada H; Kimura H; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Radiother Oncol; 2008 Aug; 88(2):192-5. PubMed ID: 18653257
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
Lee JD; Ueno M; Miyajima Y; Nakamura H
Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
[TBL] [Abstract][Full Text] [Related]
11. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
12. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
13. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors.
Zhuo JC; Cai J; Soloway AH; Barth RF; Adams DM; Ji W; Tjarks W
J Med Chem; 1999 Apr; 42(7):1282-92. PubMed ID: 10197971
[TBL] [Abstract][Full Text] [Related]
16. [Boron delivery system for neutron capture therapy of cancer].
Nakamura H
Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
[No Abstract] [Full Text] [Related]
17. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
19. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
20. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
